Samsung Betting Billions on Biosimilars

The Samsung Group, one of the world's largest conglomerates, has announced its intention to invest billions of dollars to become a major player in the expanding biosimilars market. Read the Bloomberg report here.


More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments